Acute onset of neutrophilic dermatosis in patients after therapy with a COX-2-specific inhibitor.
Smith
Kathleen J
KJ
Departments of Dermatology and Pathology, University of Alabama, Birmingham, Alabama 35294-0009, USA.
Skelton
Henry
H
D000328:Adult; D001168:Arthritis / Q000188:drug therapy; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D005260:Female; D006801:Humans; D007783:Lactones / Q000008:administration & dosage / Q000009:adverse effects*; D007868:Leg Dermatoses / Q000139:chemically induced* / Q000473:pathology; D009504:Neutrophils / Q000473:pathology*; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced* / Q000473:pathology; D013450:Sulfones
D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib